Screening for Breast Cancer: Update on Guidelines and the Ongoing Controversy
Overview
In the United States, breast cancer is the second leading cause of death after lung cancer. According to the American Cancer Society, there will be 234,580 new diagnoses of invasive breast cancer (2,240 men; 232,340 women), 64,640 new diagnoses of DCIS, and 40,030 deaths from breast cancer (410 men; 39,620 women) in 2013. It is now estimated that one in eight women will develop breast cancer during their lifetime and 70-80% of these women will have no identifiable elevated risk factors. This CME activity encompasses the most recent guidelines on screening initiation, screening intervals and screening follow-up.
Learning Objectives
- Summarize the existing data and controversies surrounding screening for breast cancer.
- List screening tools and provide supporting evidence for these options.
- Summarize screening recommendations and interval screenings.
Course Faculty
Priscilla J. Slanetz MD, MPH, FACR
Associate Professor of Radiology, Harvard Medical School
Program Director, Radiology Residency, BIDMC
Course Fees: Free
Format: Text and Graphics
CME Credit: 1 AMA PRA Category 1 Credit™, risk management study
